The Claim
Beta-casomorphin-7 (BCM-7), a peptide released during digestion of A1 beta-casein, reduces cysteine uptake in human gut and neuronal cells, thereby limiting glutathione synthesis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Beta-casomorphin-7, a peptide formed when digesting A1 beta-casein milk protein, decreases cysteine absorption in human gut and nerve cells, which reduces the production of glutathione.
See the scientific wording
Beta-casomorphin-7 (BCM-7), a peptide released during digestion of A1 beta-casein, is hypothesized to reduce cysteine uptake in human gut and neuronal cells, thereby limiting glutathione synthesis, based on in vitro cell culture studies.
When a specific protein in certain milk breaks down, it releases a peptide that binds to receptors in the gut and brain cells. This binding blocks the cells from taking in cysteine, a building block needed to make glutathione. Without enough cysteine, glutathione levels drop, leaving cells more vulnerable to damage from oxidative stress.
What the research says
1 studyThis study found that milk with A1 beta-casein leads to lower levels of a key antioxidant called glutathione in the body, likely because a peptide (BCM-7) from that milk blocks the absorption of a nutrient (cysteine) needed to make it — just like the lab studies suggested.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.